Overview

Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
It is hypothesized that the acetylcholinesterase inhibitor, donepezil, will increase acute cerebrospinal fluid (CSF) actylcholine levels in healthy volunteers following a 5mg single dose oral administration.
Details
Lead Sponsor:
Pfizer
Treatments:
Acetylcholine
Donepezil